Lacosamide Oral Solution
NDC 73190-103, Lacosamide, solution, from AvKARE.
- Product NDC
- 73190-103
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219699
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/73190-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73190-103-20 | 73190010320 | 200 mL in 1 BOTTLE (73190-103-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5b10986e-0809-b6d1-e063-6394a90a5738
Use it
Look up 73190-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73190-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73190-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.